BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sygnature Chemical Services Strengthens Scientific Team: Dr Michael Knaggs Appointed As Head Of Computational Chemistry


1/21/2010 1:24:29 PM

Nottingham, UK 21st January 2010 – Sygnature Chemical Services Ltd., a leading UK-based provider of premium discovery chemistry services to the global pharmaceutical industry, today announced the appointment of Dr Michael (“Mick”) Knaggs as Head of Computational Chemistry.

Dr Simon Hirst, Sygnature’s Chief Executive Officer commented, “I welcome Mick to Sygnature Chemical Services, he is a great addition to our scientific team and has joined Sygnature at an opportune time. Mick has over 10 years computational chemistry experience in the pharmaceutical industry and academia in the UK and USA. He has good experience of undertaking virtual screening projects (structure-based and ligand-based approaches) in a variety of targets (CNS, tropical diseases, anti-virals anti-bacterials etc), pharmacophore modelling, QSAR and library design; as well as protein modelling and simulation work. Sygnature has experienced a growing interest in its computational chemistry services over the past few months, both as a stand-alone service and to support medicinal chemistry-based projects. Mick is already contributing his expertise into several on-going projects and has been involved in a number of proposals for new projects which will involve computational chemistry in some form.

Dr Michael Knaggs added, “I am pleased to join the company at a time when Sygnature has been experiencing an increase in interest in its discovery chemistry services, and has just formed a strategic alliance with Cyprotex to provide a fully-integrated discovery chemistry/DMPK services. Computational chemistry forms a key component of the drug discovery process – from hit identification through virtual screening to guiding structural modifications to enhance potency and selectivity during medicinal chemistry-driven optimisation. I am looking forward to working with Simon and the rest of the Sygnature team.”

About Sygnature Chemical Services Ltd.

Sygnature Chemical Services, founded in 2004, is a leading Nottingham, UK-based provider of premium discovery chemistry services (medicinal chemistry, synthetic chemistry, array/focused library and computational chemistry). The company delivers high value and quality to its clients by applying in-house scientific expertise and ‘state-of-the-art’ technologies to the discovery of novel drug candidates. Sygnature’s team of 34 industry-experienced chemists (75% with PhDs) undertakes key elements of the drug discovery process, such as hit identification, hit-to-lead and lead optimisation, to afford novel compounds in a time-efficient and cost-effective manner. We work closely with our clients’ scientists to accelerate their drug candidates into development and thereby increase the value of their R&D discovery programmes. Over the past five years, Sygnature has established an enviable reputation and excellent track record of success with an international client base. For more information on Sygnature visit www.sygnaturechem.com.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES